Correction to: Leukemia (2018);
published online 28 September 2018
In the original version of this Article the following authors were omitted:
• Claudia Rossig (University Children’s Hospital of Münster, Münster, Germany)
• Paul Schlegel (University Children’s Hospital of Würzburg, Würzburg, Germany)
• Jean-Pierre Bourquin (University Children’s Hospital, Switzerland)
• Aurelie Cabannes (University Hospital Saint-Louis, Paris, France)
• Luciano Dalla-Pozza (Children’s Hospital at Westmead, Sydney, Australia)
• Sarah Alexander (The Hospital for Sick Children, Toronto, Canada)
• Michel Zwaan (Erasmus MC, University Medical Center, Rotterdam, the Netherlands)
• Amrana Quereshi (Oxford University Hospitals, UK)
• Keith August (Children’s Mercy Hospital, Kansas City, MO, USA)
All authors agree to the inclusion of these added authors
The acknowledgments section has also been updated to read:
We thank the research coordinators and following physicians at pediatric cancer centers for contributing data to this project: Prashant Hiwarkar and Jayashree Motwani, Birmingham Women’s and Children’s Hospital, UK; Kelly Maloney, Children’s Hospital of Colorado, USA; Mylene Bassal, Children’s Hospital of Eastern Ontario, Canada; Yoav Messinger and Joanna Perkins, Children’s Hospital of Minnesota, USA; Van Huynh, Children’s Hospital of Orange County, USA; Richard Ho, Children’s Hospital at Vanderbilt, USA; Joanne Chuah and Jessa Morales, Children’s Hospital at Westmead, Australia; Donald Wells, Dell Children’s Hospital, USA; Nicolas Boissel, Hospital Saint-Louis, France; Tannie Huang, Kaiser Permanente, USA; Stacey Marjerrison, McMaster Children’s Hospital, Canada; William Carroll and Joanna Pierro, New York University Langone Medical Center, USA; Ajay Vora, Sheffield Children’s Hospital, UK; Donna Lancaster, The Royal Marsden Hospital, UK; Lucie Šrámková, University Hospital Motol, Czech Republic; Chatchawin Assanasen, University of Texas Health Science Center, San Antonio, USA; Rupert Handgretinger, University of Tübingen, Germany.
This has now been corrected in both the PDF and HTML versions of the Article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Bhojwani, D., Sposto, R., Shah, N.N. et al. Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia. Leukemia 33, 1061–1062 (2019). https://doi.org/10.1038/s41375-019-0426-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41375-019-0426-8